These diagnostic advances could be life-changing for the almost half-million people who develop DR-TB annually, but they have yet to reach the most needy patients. The task at hand is to support national TB programs, laboratories, clinicians, all of whom make up the diagnostic front line, to provide timely and accurate testing for DR-TB patients. Read more here.
top of page
Recent Posts
See AllPhumeza Tisile was treated for MDR-TB in 2010 and suffered severe side effects from the drug, kanamycin. Her experiences drove her to...
110
The WHO has released new guidelines for prophylactic TB treatments. Among the updates to the guidelines are adjusted dosage...
90
The TB-CAPT consortium released a new study recently that showed that the new Xpert MTB/XDR testing can provide signigificantly faster...
140
bottom of page
Comments